Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Mainz Biomed B.V.

Mainz Biomed B.V. (MYNZ) Stock Overview

Explore Mainz Biomed B.V.’s financial performance, market position, analyst ratings, and future outlook.

MYNZ●NASDAQ
HealthcareMedical - Diagnostics & Research
$3.59
$0.03(0.84%)
U.S. Market opens in 12h 45m

Mainz Biomed B.V. (MYNZ)

Meyka AI Score

Z

Key Financials

Market Cap14.7M
P/E Ratio-1.17
EPS (TTM)$-5.28
ROE-10.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$0.98
1 Year Target$0.00

MYNZ Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Mainz Biomed B.V. (NASDAQ: MYNZ) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Mainz Biomed B.V.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MYNZ on the NASDAQ shows an RSI of 51.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Mainz Biomed B.V.'s NASDAQ-traded stock include a P/E ratio of -1.17 and a market capitalization of 14.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MYNZ on the NASDAQ.

Price Performance (NASDAQ: MYNZ)

1-Day Change
103.98%
5-Day Change
96.17%
1-Month Change
0.84%
3-Month Change
581.21%
6-Month Change
199.17%
Year-to-Date (YTD) Change
220.54%
1-Year Change
158.27%
3-Year Change
-98.06%
5-Year Change
-99.10%
All-Time (Max) Change
-99.10%

Contact Information

https://quantum-cyber.ai
49 6131 554 2860
Robert Koch Strasse 50, Mainz, NaN, 55129

Company Facts

190 Employees
IPO DateNov 5, 2021
CountryDE

Frequently Asked Questions